tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Ileus D045823 3 associated lipids
Rectal Diseases D012002 1 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Morena M et al. Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients. 2000 Transplant. Proc. pmid:11134805
Fischer S et al. Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation. 2000 Transplant. Proc. pmid:11134815
Sam WJ et al. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients. 2000 Br J Clin Pharmacol pmid:11136292
Sestak K et al. Tacrolimus-FK506 induced immunosuppression in gnotobiotic piglets. 2000 Vet. Immunol. Immunopathol. pmid:11137126
Michnick SW Chemical biology beyond binary codes. 2000 Chem. Biol. pmid:11137822
Lopau K et al. Tacrolimus in acute renal failure: does L-arginine-infusion prevent changes in renal hemodynamics? 2000 Transpl. Int. pmid:11140242
Abraham KA et al. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus. 2000 Transpl. Int. pmid:11140243
Haas M et al. Hypothyroidism as a cause of tacrolimus intoxication and acute renal failure: a case report. 2000 Wien. Klin. Wochenschr. pmid:11144010
Barone GW et al. The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria. 2001 J Clin Pharmacol pmid:11144989
Bekersky I et al. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. 2001 J. Am. Acad. Dermatol. pmid:11145792
Hanifin JM et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. 2001 J. Am. Acad. Dermatol. pmid:11145793
Soter NA et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. 2001 J. Am. Acad. Dermatol. pmid:11145794
Paller A et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. 2001 J. Am. Acad. Dermatol. pmid:11145795
Kang S et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. 2001 J. Am. Acad. Dermatol. pmid:11145796
Drake L et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. 2001 J. Am. Acad. Dermatol. pmid:11145797
Vallejo C et al. Resolution of cyclosporine-induced gingival hyperplasia resistant to azithromycin by switching to tacrolimus. 2001 Haematologica pmid:11146586
Nghiem P "Topical immunomodulators?": introducing old friends and a new ally, tacrolimus. 2001 J. Am. Acad. Dermatol. pmid:11148486
Butani L and Makker SP Conversion from tacrolimus to neoral for postrenal transplant diabetes. 2000 Pediatr. Nephrol. pmid:11149106
Gondo H et al. Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation. 2000 Bone Marrow Transplant. pmid:11149744
Remitz A et al. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. 2001 J. Allergy Clin. Immunol. pmid:11150013
Emre S et al. Safety and risk of using pediatric donor livers in adult liver transplantation. 2001 Liver Transpl. pmid:11150421
Nagatomo I et al. Effects of MK-801, dantrolene, and FK506 on convulsive seizures and brain nitric oxide production in seizure-susceptible EL mice. 2001 Brain Res. pmid:11150489
Hamar P et al. Interleukin-2-dependent mechanisms are involved in the development of glomerulosclerosis after partial renal ablation in rats. 2001 Mar-Apr Exp. Nephrol. pmid:11150862
Bain JR Peripheral nerve and neuromuscular allotransplantation: current status. 2000 Microsurgery pmid:11150988
Gruber SA et al. Local drug delivery to composite tissue allografts. 2000 Microsurgery pmid:11150992
König A et al. Intravascular ultrasound for assessment of coronary allograft vasculopathy. 2000 Z Kardiol pmid:11151792
Kainz A et al. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. 2000 Transplantation pmid:11152103
MacDonald AS Impact of immunosuppressive therapy on hypertension. 2000 Transplantation pmid:11152235
Cather JC et al. Cyclosporine and tacrolimus in dermatology. 2001 Dermatol Clin pmid:11155577
Tolou-Ghamari Z et al. In vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation. 2000 Clin. Chem. Lab. Med. pmid:11156362
Mathis AS and Friedman GS Coadministration of digoxin with itraconazole in renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11157404
Prestle J et al. Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. 2001 Circ. Res. pmid:11157671
Ligtenberg G et al. Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. 2001 J. Am. Soc. Nephrol. pmid:11158228
Coupes BM et al. Plasma transforming growth factor beta(1) and platelet activation: implications for studies in transplant recipients. 2001 Nephrol. Dial. Transplant. pmid:11158413
Hanauer SB and Dassopoulos T Evolving treatment strategies for inflammatory bowel disease. 2001 Annu. Rev. Med. pmid:11160781
Rose N and Lever A The rapamycin sensitivity of human T-cell leukaemia virus type I-induced T-cell proliferation is mediated independently of the polypyrimidine motifs in the 5' long terminal repeat. 2001 J. Gen. Virol. pmid:11161283
Peeling J et al. Effect of FK-506 on inflammation and behavioral outcome following intracerebral hemorrhage in rat. 2001 Exp. Neurol. pmid:11161622
Hofbauer LC et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. 2001 Biochem. Biophys. Res. Commun. pmid:11162519
Wakugawa M et al. Evaluation of mite allergen-induced Th1 and Th2 cytokine secretion of peripheral blood mononuclear cells from atopic dermatitis patients: association between IL-13 and mite-specific IgE levels. 2001 J. Dermatol. Sci. pmid:11164708
Baran DA et al. Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results. 2001 J. Heart Lung Transplant. pmid:11166613
Tanaka K et al. Immunosuppressive and non-immunosuppressive immunophilin ligands improve H(2)O(2)-induced cell damage by increasing glutathione levels in NG108-15 cells. 2001 Brain Res. pmid:11166708
Macleod MR et al. Serum withdrawal causes apoptosis in SHSY 5Y cells. 2001 Brain Res. pmid:11166724
Boulad F et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. 2000 Br. J. Haematol. pmid:11167755
Jørgensen PF et al. Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production. 2001 Scand. J. Immunol. pmid:11169223
Bayguinov O et al. Muscarinic stimulation increases basal Ca(2+) and inhibits spontaneous Ca(2+) transients in murine colonic myocytes. 2001 Am. J. Physiol., Cell Physiol. pmid:11171588
Manzarbeitia C et al. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients. 2001 Liver Transpl. pmid:11172391
Shibazaki Y et al. Effect of the immunosuppressant drug FK506 on neonatal cerebral mitochondrial function and energy metabolism after transient intrauterine ischemia in rats. 2001 Brain Res. pmid:11172783
Panhans-Gross A et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). 2001 J. Allergy Clin. Immunol. pmid:11174203
Hauk PJ and Leung DY Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? 2001 J. Allergy Clin. Immunol. pmid:11174211
Paller AS Use of nonsteroidal topical immunomodulators for the treatment of atopic dermatitis in the pediatric population. 2001 J. Pediatr. pmid:11174611